Correction to: Alzheimers Res Ther (2019) 11:28
https://doi.org/10.1186/s13195-019-0475-2
Following publication of the original article [1], the authors reported that Fig. 6 contains a mistake. The Fig. 6f is a duplicate of Fig. 6e of Braak 5.
The correct Fig. 6f is shown below.
a–h RNAscope in situ hybridization of control and AD brain samples with different BRAAK numbers (a). Green represents NLRP3, yellow NRXN3, and magenta NEUN. The red arrow indicates colocalization of three probes in the same cell. H-score correlations of NRXN3 and NLRP3 intensities with BRAAK numbers (b)
Reference
Hishimoto A, et al. Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease. Alzheimers Res Ther. 2019;11:28 https://doi.org/10.1186/s13195-019-0475-2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Hishimoto, A., Pletnikova, O., Lang, D.L. et al. Correction to: Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease. Alz Res Therapy 11, 39 (2019). https://doi.org/10.1186/s13195-019-0493-0
Published:
DOI: https://doi.org/10.1186/s13195-019-0493-0